PPAR-alpha/gamma AGONISTS - Banco de Patentes
Back PPAR-alpha/gamma AGONISTS
PPAR-alpha/gamma AGONISTS

Researchers from INCLIVA has synthesised a novel family of drug candidates with dual PPAR-alpha/ activity. This compounds are characterized by their improvement of lipid and glycaemic parameters in plasma, as well as their anti-inflammatory effect with a low or almost absent toxicity.
INDUSTRIAL PROPERTY RIGHTS
Priority patent application filed in December 2017.
FURTHER INFORMATION
Sectoral environment: Health Promotion and Efficient Health
Entity: Fundación para la Investigación del Hospital Cl´nico de la COmunitat Valenciana (INCLIVA)
Entity: Fundación para la Investigación del Hospital Cl´nico de la COmunitat Valenciana (INCLIVA)
CONTACT:
INCLIVA Innovation Unit
uai@incliva.es